
Dr. John Galgiani, head of UArizona’s Valley Fever Center for Excellence and BIO5 member, is heading up vaccine research at the center and is working on a vaccine shown to prevent valley fever in mice. Dr. Galgiani discusses the vaccine’s progress and the different hurdles valley fever researchers face in developing a viable vaccine for humans.
Related